Preoperative Intraarterial Chemoembolization Combined With Radiotherpy in Locally Advanced Rectal Cancer
NCT03601156 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204
Last updated 2018-08-10
Summary
Compared to postoperative chemotherapy combined with radiotherapy, preoperative chemotherapy combined with radiotherapy shows higher sphincter preservation rate and lower local recurrence rate in locally advanced rectal cancer. The purpose of this study is to evaluate the response and prognosis of intraarterial chemoembolization and intravenous infusion chemotherapy in patients with rectal T3-T4 and/or N+ rectal cancer before operation.
Conditions
Interventions
- DEVICE
-
intraarterial chemoembolization
- DEVICE
-
intravenous chemotherapy
Sponsors & Collaborators
-
Third Military Medical University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2018-12-31
- Completion
- 2020-11-30
Countries
- China
Study Locations
More Related Trials
-
Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer
NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC
NCT03156036 ·Status: COMPLETED ·Phase: PHASE2
-
Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer
NCT04231552 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Multicenter, Prospective, RCT:Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.
NCT03042000 ·Status: UNKNOWN ·Phase: NA
-
Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer
NCT06765616 ·Status: RECRUITING ·Phase: PHASE2
-
Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly
NCT02992886 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab
NCT06304545 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors
NCT06566222 ·Status: NOT_YET_RECRUITING
-
UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer
NCT05148767 ·Status: RECRUITING ·Phase: PHASE4
-
Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer
NCT05420584 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
NCT04664504 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
NCT06024356 ·Status: UNKNOWN
-
Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
NCT06017583 ·Status: RECRUITING ·Phase: PHASE3
-
Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
NCT03415763 ·Status: RECRUITING ·Phase: PHASE3
-
Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer
NCT02630056 ·Status: UNKNOWN
-
A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer
NCT07113275 ·Status: RECRUITING ·Phase: PHASE3
-
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
NCT05176964 ·Status: RECRUITING
-
Neoadjuvant Radiotherapy Followed by Transanal Endoscopic Microsurgery for T1-T2 Extraperitoneal Rectal Cancer
NCT02127645 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1
NCT02605265 ·Status: COMPLETED ·Phase: PHASE3
-
SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer
NCT06864013 ·Status: RECRUITING ·Phase: PHASE2
-
Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer
NCT06760520 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer
NCT02533271 ·Status: UNKNOWN ·Phase: PHASE3
-
Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy
NCT07260526 ·Status: RECRUITING
-
Study of Intraoperative Radiotherapy for Middle and Low Rectal Cancer
NCT03209336 ·Status: UNKNOWN ·Phase: NA
-
Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial
NCT03038256 ·Status: UNKNOWN ·Phase: PHASE2